Chronic infections and atherosclerosis

Area of Science:

• Cardiovascular Science
• Immunology
• Infectious Disease

Background:

• Atherosclerosis (AT) development is not fully explained by traditional risk factors like hypercholesterolemia, hypertension, and smoking.
• Approximately 50% of AT cases lack clear links to established risk factors, necessitating the investigation of alternative causes.
• Infectious agents and inflammation are hypothesized as potential contributors to the atherogenic process.

Purpose of the Study:

• To investigate the role of infectious agents as potential initiators or contributors to atherosclerosis.
• To explore the involvement of inflammation, whether infection-related or independent, in mediating the atherogenic process.
• To identify additional risk factors beyond traditional ones for atherosclerosis development.

Main Methods:

• Literature review and synthesis of existing research on atherosclerosis etiology.
• Analysis of studies investigating the link between specific infectious agents and cardiovascular disease.
• Examination of evidence supporting the role of inflammatory pathways in atherogenesis.

Main Results:

• Infectious agents have been implicated in the initiation and progression of atherosclerosis.
• Inflammatory responses, triggered by infections or other stimuli, are recognized as key mediators in the development of atherosclerotic lesions.
• The study highlights the multifactorial nature of atherosclerosis, involving both conventional and non-conventional risk factors.

Conclusions:

• Infectious agents and inflammation represent significant, yet often overlooked, factors in atherosclerosis pathogenesis.
• Understanding these additional risk factors is crucial for developing more comprehensive prevention and treatment strategies for atherosclerosis.
• Further research is warranted to elucidate the precise mechanisms by which infections and inflammation contribute to atherosclerosis.